Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by himmleron Jan 03, 2019 10:17am
247 Views
Post# 29181093

RE:RE:Bristol Meyers acquiring Celgene for $74 billion USD

RE:RE:Bristol Meyers acquiring Celgene for $74 billion USDI respectfully disagree...I dont think it will stimulate anything.One cannot compare PLI with Abraxis..I remember that buyout very well.To try to overlap the 2 company's is impossible.
The other thing I dont understand is the exhuberance on this BB because of some green on the share price the last day or so.What really can be expected?/I mean we hit multiple year lows a few days ago and now we're up 10 cents and everyone thinks things have changed...they havent.Aside fron PL's dismissal,everything is the same.We're in exactly the same situation as in 2018.
Thats the problem ..uncertainty about PLI's future.Investors dont like uncertainty,only gamblers like it.
I'm waiting for something concrete ,and good or bad thats what will decide the shareprice ..not misguided elation over a 10 cent jump in shareprice.It will be a very interesting year for PLI,I just hope the share price isnt wiped out because of the companys possible"strategic options" because thats a catch phrase synonymous with shareholder destruction.
I'd rather not hear that one.
Bullboard Posts